YouTube CE
YouTube CE
  • 11
  • 6 697
FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG)
FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG)
Переглядів: 14

Відео

DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria26:47DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria
DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria
Переглядів 42Місяць тому
This activity was supported by an educational grant from Travere Therapeutics. Please go to academiccme.com/CKDCE3/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
Team Management: From PCP to Nephrologist, and Supportive Patient Education to Achieve Continuity...24:37Team Management: From PCP to Nephrologist, and Supportive Patient Education to Achieve Continuity...
Team Management: From PCP to Nephrologist, and Supportive Patient Education to Achieve Continuity...
Переглядів 4083 місяці тому
Team Management: From PCP to Nephrologist, and Supportive Patient Education to Achieve Continuity of Care and Adherence to Optimal Treatment Strategies in IgA Nephropathy This activity was supported by an educational grant from Travere Therapeutics. Please go to academiccme.com/CKDCE2/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
Venous Thromboembolism - Risk Assessment45:11Venous Thromboembolism - Risk Assessment
Venous Thromboembolism - Risk Assessment
Переглядів 3304 місяці тому
This activity was supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance. Please go to academiccme.com/VTECE5/ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 7, 2025.
IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment24:23IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment
IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment
Переглядів 8335 місяців тому
This activity was supported by an educational grant from Travere Therapeutics. Please go to academiccme.com/CKDCE1/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE29:36Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE
Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE
Переглядів 1,6 тис.9 місяців тому
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to academiccme.com/VTECE3/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
Review of Clinical Trial and Real-World Data for DOAC and Other Anticoagulation Therapeutics for VTE32:24Review of Clinical Trial and Real-World Data for DOAC and Other Anticoagulation Therapeutics for VTE
Review of Clinical Trial and Real-World Data for DOAC and Other Anticoagulation Therapeutics for VTE
Переглядів 1,6 тис.10 місяців тому
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to academiccme.com/VTECE/ and complete the evaluation to receive your CE/CME Credit. Credit is available through January 31, 2025.
Strategies for the Team for Secondary Prevention, Treatment, and the Assessment of Bleeding Risk37:40Strategies for the Team for Secondary Prevention, Treatment, and the Assessment of Bleeding Risk
Strategies for the Team for Secondary Prevention, Treatment, and the Assessment of Bleeding Risk
Переглядів 1,2 тис.10 місяців тому
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to academiccme.com/VTECE2/ and complete the evaluation to receive your CE/CME Credit. Credit is available through February 26, 2025.